Abstract
59P Datopotamab deruxtecan (Dato-DXd) in patients with previously treated advanced non-small cell lung cancer (NSCLC): Nonsquamous (NSQ) histology in the phase III TROPION-Lung01 trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have